Naturally Splendid (TSXV:NS,FWB:50N,OTCQB:NSPDF) announced a definitive development and manufacturing agreement with Laguna Blends Inc. Laguna has now placed an initial Purchase Order of $100,000.00 CDN for HempOmega™ Infused Hemp Protein Formulations; and anticipates ordering a further $1,500,000 of the HempOmega™ Infused Protein Products in the first year of the Agreement and $4,500,000 of the HempOmega™ Infused Hemp Protein Products in the second year of the Agreement.
As quoted in the press release:

Under the Agreement, Naturally Splendid is granting Laguna, (i) a license to include the HempOmega™ trade-mark on the Laguna HempOmega™ Infused Protein Products, as specified on a white private label agreement, (ii) a worldwide exclusive on these specific formulations dependent on Laguna achieving certain sales targets (iv) and the right and license to Laguna to sell the Laguna HempOmega™ Infused Protein Products. Laguna must meet the following minimum gross sales targets for the Laguna HempOmega™ Infused Protein Products in order to retain exclusive rights to these products: $1,600,000 in the first year after entry into the Agreement, and $4,500,000 in the second year after entry into the Agreement.
Stuart Gray, President, CEO and Director of Laguna Blends Inc. states, “We would like to thank Naturally Splendid for the research and development of these four (4) initial products. Our market research indicates a strong pull for high quality, plant based omega and protein products. In this area, Naturally Splendid scores a ten out of ten in my opinion. Laguna affiliates will begin to retail these products in the United States and Canada.”

Naturally Splendid CEO, Craig Goodwin, said:

We are pleased to receive this first Purchase Order from Laguna Blends. Naturally Splendid has developed four (4) unique hemp protein formulations enhanced with HempOmega™ and flavoured to meet Laguna’s requirements. Laguna has been granted exclusive rights to these specific four formulations. Naturally Splendid retains all of its rights to HempOmega™ and will continue to cultivate additional clients for this ingredient.

Click here for the full Naturally Splendid (TSXV:NS,FWB:50N,OTCQB:NSPDF) press release.
Click here for the Naturally Splendid (TSXV:NS,FWB:50N,OTCQB:NSPDF) profile.

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less